SUMMARY
- Bengaluru-based healthcare startup 4baseCare, has secured $6 million in its Series A funding round, with Yali Capital leading the investment.
- The company plans to use this funding to grow and diversify its product offerings and to expand its operations across India, as well as into other Asian and Middle Eastern countries.
- Cofounded by Hitesh Goswami and Kshitij Rishi in 2018, 4baseCare offers specialized cancer treatment services through cutting-edge genomics and digital health technology.
Bengaluru-based healthcare startup 4baseCare, has secured $6 million in its Series A funding round, with Yali Capital leading the investment.
The company plans to use this funding to grow and diversify its product offerings and to expand its operations across India, as well as into other Asian and Middle Eastern countries.
4baseCare, established in 2018 by Hitesh Goswami and Kshitij Rishi, offers specialized cancer treatment services through cutting-edge genomics and digital health technology. Its genomic tests have been successful in providing results across South East Asia, assisting more than 10,000 cancer patients.
The company’s genomic tests include Indiegene, which it calls the first cancer gene panel specifically designed for the Indian population for biomarker testing.
In the coming months, 4baseCare aims to set up genomics laboratories in the Philippines, Nepal, and Dubai. Additionally, it plans to focus on genomics and digital health to enhance related areas such as advanced data analysis, improved clinical insights, and treatment plans supported by data.
